Advanced company searchLink opens in new window

ROSEMONT PHARMA LIQUIDS LIMITED

Company number 13436394

Filter by category

Filter by category


Confirmation statement filters, selecting an input will reload the page.
Confirmation statement filters, selecting an input will reload the page.

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
13 Mar 2026 AA Accounts for a dormant company made up to 31 December 2025
30 Jan 2026 TM01 Termination of appointment of Timothy Mark Busby as a director on 21 January 2026
19 Dec 2025 AP01 Appointment of Mr Gavin Wood as a director on 17 December 2025
24 Jul 2025 TM01 Termination of appointment of Howard Langton Taylor as a director on 23 July 2025
15 Jul 2025 AA Audit exemption subsidiary accounts made up to 31 December 2024
15 Jul 2025 PARENT_ACC Consolidated accounts of parent company for subsidiary company period ending 31/12/24
15 Jul 2025 GUARANTEE2 Audit exemption statement of guarantee by parent company for period ending 31/12/24
15 Jul 2025 AGREEMENT2 Notice of agreement to exemption from audit of accounts for period ending 31/12/24
01 Jul 2025 GUARANTEE2 Audit exemption statement of guarantee by parent company for period ending 31/12/24
01 Jul 2025 AGREEMENT2 Notice of agreement to exemption from audit of accounts for period ending 31/12/24
20 Jun 2025 CS01 Confirmation statement made on 1 June 2025 with no updates
11 Jun 2024 CS01 Confirmation statement made on 1 June 2024 with no updates
13 May 2024 AA Accounts for a small company made up to 31 December 2023
21 Jun 2023 CS01 Confirmation statement made on 1 June 2023 with no updates
10 May 2023 AA Accounts for a small company made up to 31 December 2022
18 Jul 2022 AA Accounts for a small company made up to 31 December 2021
01 Jun 2022 CS01 Confirmation statement made on 1 June 2022 with updates
25 Nov 2021 CERTNM Company name changed essential pharma liquids LIMITED\certificate issued on 25/11/21
  • NM01 ‐ Change of name by resolution
  • RES15 ‐ Change company name resolution on 2021-11-22
25 Nov 2021 PSC07 Cessation of Guy Semmens as a person with significant control on 22 November 2021
25 Nov 2021 AP01 Appointment of Mr Iain Fawcett as a director on 22 November 2021
25 Nov 2021 AP01 Appointment of Mr Timothy Mark Busby as a director on 22 November 2021
25 Nov 2021 AP01 Appointment of Mr Howard Langton Taylor as a director on 22 November 2021
25 Nov 2021 AA01 Current accounting period shortened from 30 June 2022 to 31 December 2021
25 Nov 2021 PSC02 Notification of Rosemont Pharmaceuticals Limited as a person with significant control on 22 November 2021
25 Nov 2021 PSC07 Cessation of Cortex 3 Guernsey Limited as a person with significant control on 22 November 2021